Advertisement
ASND vs MEDI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASND is a StrongBuy and MEDI is a Hold.
ASND's RSI Oscillator ascends from oversold territory
The RSI Indicator for ASND moved out of oversold territory on September 24, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 18 similar instances when the indicator left oversold territory. In 16 of the 18 cases the stock moved higher. This puts the odds of a move higher at 89%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 19, 2026. You may want to consider a long position or call options on ASND as a result. In 72 of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.
The Moving Average Convergence Divergence (MACD) for ASND just turned positive on October 09, 2026. Looking at past instances where ASND's MACD turned positive, the stock continued to rise in 36 of 57 cases over the following month. The odds of a continued upward trend are 63%.
ASND moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1.87% 3-day Advance, the price is estimated to grow further. Considering data from situations where ASND advanced for three days, in 185 of 264 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The 10-day moving average for ASND crossed bearishly below the 50-day moving average on September 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 18 of 21 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASND declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
ASND broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ASND entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 12 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. ASND’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 53 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 73 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.145) is normal, around the industry mean (3.043). P/E Ratio (20.748) is within average values for comparable stocks, (-1.361). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (133.535) among similar stocks. P/S Ratio (12.970) is also within normal values, averaging (438.009).
MEDI's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for MEDI turned positive on October 15, 2026. Looking at past instances where MEDI's MACD turned positive, the stock continued to rise in 44 of 48 cases over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on MEDI as a result. In 69 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 87%.
MEDI moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1.05% 3-day Advance, the price is estimated to grow further. Considering data from situations where MEDI advanced for three days, in 185 of 235 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MEDI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
MEDI broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for MEDI entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
ASND | ||
|---|---|---|
OUTLOOK RATING 1..100 | 31 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 90 Overvalued | |
PROFIT vs RISK RATING 1..100 | 53 | |
SMR RATING 1..100 | 12 | |
PRICE GROWTH RATING 1..100 | 48 | |
P/E GROWTH RATING 1..100 | 73 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| ASND | MEDI | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 89% | N/A |
| Stochastic ODDS (%) | 2 days ago 89% | 2 days ago 76% |
| Momentum ODDS (%) | 2 days ago 78% | 2 days ago 87% |
| MACD ODDS (%) | 2 days ago 63% | 2 days ago 90% |
| TrendWeek ODDS (%) | 2 days ago 70% | 2 days ago 81% |
| TrendMonth ODDS (%) | 2 days ago 74% | 2 days ago 86% |
| Advances ODDS (%) | 2 days ago 70% | 3 days ago 79% |
| Declines ODDS (%) | 9 days ago 72% | 12 days ago 77% |
| BollingerBands ODDS (%) | 2 days ago 88% | 2 days ago 76% |
| Aroon ODDS (%) | 2 days ago 85% | 2 days ago 83% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ASND’s FA Score shows that 1 FA rating(s) are green while .
- ASND’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ASND’s TA Score shows that 5 TA indicator(s) are bullish.
- ASND’s TA Score: 5 bullish, 5 bearish.
Price Growth
ASND (@Biotechnology) experienced а +8.04% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was -16.30%, and the average quarterly price growth was -16.78%.
Reported Earning Dates
ASND is expected to report earnings on Nov 11, 2026.
Industries' Descriptions
@Biotechnology (+1.24% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
MEDI and
Correlation & Price change
A.I.dvisor indicates that over the last year, MEDI has been loosely correlated with LLY. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if MEDI jumps, then LLY could also see price increases.
| Ticker / NAME | Correlation To MEDI | 1D Price Change % | ||
|---|---|---|---|---|
| MEDI | 100% | -0.97% | ||
| LLY - MEDI | 66% Loosely correlated | -2.54% | ||
| ABBV - MEDI | 52% Loosely correlated | +0.16% | ||
| MRK - MEDI | 49% Loosely correlated | -1.34% | ||
| PFE - MEDI | 48% Loosely correlated | -1.28% | ||
| TECH - MEDI | 47% Loosely correlated | -0.10% | ||
More | ||||